DSP Nifty Healthcare ETF

Regular

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.
Direct

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.

Equity Holding : 99.93% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 99.93%

No of Stocks : 20 (Category Avg - 53.77) | Large Cap Investments : 43.2%| Mid Cap Investments : 25.63% | Small Cap Investments : 0.75% | Other : 30.35%

Portfolio Summary (as on 31st Aug,2025)

Particulars	This Scheme	Category
No. of Stocks	20	76.39
Top 5 Stock Weight	52.41%	37.92%
Top 10 Stock Weight	77.55%	54.82%
Top 3 Sector Weight	99.93%	34.31%

Category - Index Funds/ETFs

Particulars	This Scheme	Category
Average mcap (Cr)	34540.15	112532.95
Holdings in large cap stocks	43.2%	51.43%
Holdings in mid cap stocks	25.63%	15.85%
Holdings in small cap stocks	0.75%	8.2%

Category - Index Funds/ETFs

Top 10 Stocks holding in Portfolio (as on 31st Aug,2025)

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
# Sun Pharmaceutical Industries Ltd.	Pharmaceuticals	18.8	17.95%	0.00%	22.67% (Sep 2024)	18.49% (Jul 2025)	11.77 k	222.00
# Cipla Ltd.	Pharmaceuticals	9.8	9.34%	0.00%	9.91% (Sep 2024)	8.77% (Jun 2025)	6.14 k	115.00
# Max Healthcare Institute Ltd.	Hospital	9.4	8.96%	0.00%	9.81% (Jun 2025)	7.11% (Aug 2024)	8.11 k	153.00
# Divis Laboratories Ltd.	Pharmaceuticals	8.5	8.13%	0.00%	9.11% (May 2025)	7.24% (Aug 2024)	1.39 k	26.00
# Apollo Hospitals Enterprises Ltd.	Hospital	8.4	8.03%	0.00%	8.02% (Jan 2025)	7.37% (Mar 2025)	1.10 k	20.00
# Dr. Reddys Laboratories Ltd.	Pharmaceuticals	8.4	8.01%	0.00%	9.56% (Aug 2024)	7.7% (Mar 2025)	6.64 k	125.00
# Fortis Healthcare Ltd.	Hospital	5.2	4.96%	0.00%	4.49% (Jul 2025)	0% (Aug 2024)	5.69 k	107.00
# Lupin Ltd.	Pharmaceuticals	5	4.78%	0.00%	6.1% (Dec 2024)	4.69% (Jul 2025)	2.64 k	49.00
# Torrent Pharmaceuticals Ltd.	Pharmaceuticals	4.1	3.89%	0.00%	3.93% (Jul 2025)	3.29% (Oct 2024)	1.14 k	21.00
# Laurus Labs Ltd.	Pharmaceuticals	3.7	3.50%	0.00%	3.44% (Jul 2025)	1.99% (Sep 2024)	4.27 k	80.00

- indicates change in weight in the portfolio. # indicates a new entry.

View complete holding

Complete equity Portfolio (as on 31st Aug,2025)

None
Sector
M-Cap

Help me understand this table

Stock Invested in	Sector	Sector Total	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty	M-Cap	GroupName
# Sun Pharmaceutical Industries Ltd.	Pharmaceuticals	76.74	18.8	17.95%	0.00%	22.67% (Sep 2024)	18.49% (Jul 2025)	11.77 k	222.00	Large Cap	43.2
# Cipla Ltd.	Pharmaceuticals	76.74	9.8	9.34%	0.00%	9.91% (Sep 2024)	8.77% (Jun 2025)	6.14 k	115.00	Large Cap	43.2
# Max Healthcare Institute Ltd.	Hospital	21.95	9.4	8.96%	0.00%	9.81% (Jun 2025)	7.11% (Aug 2024)	8.11 k	153.00	Other	30.35
# Divis Laboratories Ltd.	Pharmaceuticals	76.74	8.5	8.13%	0.00%	9.11% (May 2025)	7.24% (Aug 2024)	1.39 k	26.00	Large Cap	43.2
# Apollo Hospitals Enterprises Ltd.	Hospital	21.95	8.4	8.03%	0.00%	8.02% (Jan 2025)	7.37% (Mar 2025)	1.10 k	20.00	Mid Cap	25.63
# Dr. Reddys Laboratories Ltd.	Pharmaceuticals	76.74	8.4	8.01%	0.00%	9.56% (Aug 2024)	7.7% (Mar 2025)	6.64 k	125.00	Other	30.35
# Fortis Healthcare Ltd.	Hospital	21.95	5.2	4.96%	0.00%	4.49% (Jul 2025)	0% (Aug 2024)	5.69 k	107.00	Other	30.35
# Lupin Ltd.	Pharmaceuticals	76.74	5	4.78%	0.00%	6.1% (Dec 2024)	4.69% (Jul 2025)	2.64 k	49.00	Large Cap	43.2
# Torrent Pharmaceuticals Ltd.	Pharmaceuticals	76.74	4.1	3.89%	0.00%	3.93% (Jul 2025)	3.29% (Oct 2024)	1.14 k	21.00	Mid Cap	25.63
# Laurus Labs Ltd.	Pharmaceuticals	76.74	3.7	3.50%	0.00%	3.44% (Jul 2025)	1.99% (Sep 2024)	4.27 k	80.00	Other	30.35
# Glenmark Pharmaceuticals Ltd.	Pharmaceuticals	76.74	3.2	3.03%	0.00%	3.23% (Jul 2025)	2.23% (Apr 2025)	1.64 k	31.00	Mid Cap	25.63
# Aurobindo Pharma Ltd.	Pharmaceuticals	76.74	3.1	3.00%	0.00%	4.93% (Aug 2024)	3.2% (Jul 2025)	3.05 k	58.00	Large Cap	43.2
# Alkem Laboratories Ltd.	Pharmaceuticals	76.74	3.1	2.98%	0.00%	3.46% (Aug 2024)	2.72% (Jul 2025)	587.00	11.00	Mid Cap	25.63
# Mankind Pharma Ltd.	Pharmaceuticals	76.74	3	2.91%	0.00%	3.02% (May 2025)	0% (Aug 2024)	1.23 k	23.00	Other	30.35
# Zydus Lifesciences Ltd.	Pharmaceuticals	76.74	2.7	2.56%	0.00%	3.17% (Aug 2024)	2.38% (Apr 2025)	2.73 k	52.00	Mid Cap	25.63
# Biocon Ltd.	Pharmaceuticals	76.74	2.3	2.18%	0.00%	2.36% (Jul 2025)	1.56% (Apr 2025)	6.55 k	123.00	Mid Cap	25.63
# Ipca Laboratories Ltd.	Pharmaceuticals	76.74	2.1	2.01%	0.00%	2.47% (Dec 2024)	2% (Jun 2025)	1.52 k	28.00	Other	30.35
# Abbott India Ltd.	Pharmaceuticals	76.74	1.8	1.72%	0.00%	2.01% (Feb 2025)	1.59% (Jan 2025)	57.00	1.00	Mid Cap	25.63
# Syngene International Ltd.	Healthcare research, analytics & technology	1.24	1.3	1.24%	0.00%	1.93% (Nov 2024)	1.25% (Jun 2025)	2.07 k	39.00	Mid Cap	25.63
# Granules India Ltd.	Pharmaceuticals	76.74	0.8	0.75%	0.00%	1.09% (Aug 2024)	0.69% (Jul 2025)	1.58 k	29.00	Small Cap	0.75

- indicates change in weight in the portfolio. # indicates a new entry.

New Stocks added in Portfolio (in 1 month period ending 31st Aug,2025)

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
No new entrants in the portfolio in the last month.

Stocks removed from Portfolio (in 1 month period ending 31st Aug,2025)

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
No complete exits in the portfolio in the last month.

Trend in stock holdings (Top 15 Holding)

Stock	Aug 2025	Jul 2025	Jun 2025	May 2025	Apr 2025	Mar 2025	Feb 2025	Jan 2025	Dec 2024	Nov 2024	Oct 2024	Sep 2024	Aug 2024
Sun Pharmaceutical Industries Ltd.	17.95%	18.49%	18.70%	19.63%	21.20%	20.63%	21.76%	21.90%	21.87%	21.89%	22.25%	22.67%	21.95%
Cipla Ltd.	9.34%	8.79%	8.77%	8.95%	9.36%	8.95%	9.79%	9.46%	9.03%	9.60%	9.50%	9.91%	9.70%
Max Healthcare Institute Ltd.	8.96%	9.31%	9.81%	9.08%	8.76%	8.99%	9.18%	9.16%	8.99%	8.28%	8.42%	7.98%	7.11%
Dr. Reddys Laboratories Ltd.	8.01%	7.77%	8.09%	8.28%	7.75%	7.70%	8.62%	8.41%	9.10%	8.36%	8.66%	8.98%	9.56%
Divis Laboratories Ltd.	8.13%	8.42%	8.95%	9.11%	8.29%	8.08%	8.81%	8.24%	8.32%	8.89%	8.33%	7.53%	7.24%
Apollo Hospitals Enterprises Ltd.	8.03%	7.62%	7.57%	7.54%	7.56%	7.37%	7.75%	8.02%	7.93%	7.84%	7.92%	7.94%	7.79%
Lupin Ltd.	4.78%	4.69%	4.85%	5.13%	5.43%	5.40%	5.81%	5.83%	6.10%	5.63%	5.87%	5.75%	6.04%
Fortis Healthcare Ltd.	4.96%	4.49%	4.28%	3.99%	3.83%	3.98%	-	-	-	-	-	-	-
Aurobindo Pharma Ltd.	3.00%	3.20%	3.29%	3.48%	3.69%	3.58%	3.74%	3.81%	4.00%	4.03%	4.35%	4.45%	4.93%
Torrent Pharmaceuticals Ltd.	3.89%	3.93%	3.69%	3.61%	3.73%	3.72%	3.50%	3.57%	3.39%	3.47%	3.29%	3.42%	3.55%
Alkem Laboratories Ltd.	2.98%	2.72%	2.75%	2.94%	2.92%	2.86%	3.12%	3.13%	3.21%	3.35%	3.36%	3.45%	3.46%
Mankind Pharma Ltd.	2.91%	2.91%	2.71%	3.02%	2.99%	2.99%	-	-	-	-	-	-	-
Glenmark Pharmaceuticals Ltd.	3.03%	3.23%	2.73%	2.38%	2.23%	2.56%	2.44%	2.76%	2.60%	2.63%	2.84%	2.75%	2.89%
Zydus Lifesciences Ltd.	2.56%	2.43%	2.56%	2.52%	2.38%	2.44%	2.77%	2.82%	2.61%	2.75%	2.79%	2.91%	3.17%
Laurus Labs Ltd.	3.50%	3.44%	2.94%	2.59%	2.54%	2.65%	2.62%	2.67%	2.54%	2.54%	2.15%	1.99%	2.07%

Name	Type of Instrument	Weight (%)
TREPS	TREPS	0.05%
Net Receivables	Net Receivables	0.02%

Forum

hunch
MF Investment Help
Follow

20 days ago

JMFLEXICAPfund regular is howing worst performance. bought at 107.693 in jly 24 and now 97.43 how to shuffle and compensate loss View more

Posted by : hunch
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  JMFLEXICAPfund regular is howing worst performance. bought at 107.693 in jly 24 and now 97.43 how to shuffle and compensate loss
  
  Repost Cancel
You will now receive notification when someone reply to this message.
shravanashok
MF Investment Help
Follow

35 days ago

need your suggestion for sbi psu fund direct growth stay or switch View more

Posted by : shravanashok
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  need your suggestion for sbi psu fund direct growth stay or switch
  
  Repost Cancel
You will now receive notification when someone reply to this message.
The Fixed Income
Bonds
Follow

17 hrs ago

Boost Your Investment with a High-Return Secured NBFC Bond Vivriti Capital Limited – 2026 Bonds now listed on The Fixed Income ✔️ Coupon: 9.00% p.a. ✔️ Rating: CARE A+ Stable ✔️ Tenor: 1 year 1 month (Maturity: Nov 04, 2026) ✔️ Senior Secured | NBFC Bond | High Return | Listed Tap into a secured bond offering attractive returns from a trusted NBFC—perfect for investors seeking stability and growth in a short tenure. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJhbmJnPT0=/900-vivriti-capital-limited-2026?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more

Posted by : The Fixed Income
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Boost Your Investment with a High-Return Secured NBFC Bond Vivriti Capital Limited – 2026 Bonds now listed on The Fixed Income ✔️ Coupon: 9.00% p.a. ✔️ Rating: CARE A+ Stable ✔️ Tenor: 1 year 1 month (Maturity: Nov 04, 2026) ✔️ Senior Secured | NBFC Bond | High Return | Listed Tap into a secured bond offering attractive returns from a trusted NBFC—perfect for investors seeking stability and growth in a short tenure. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJhbmJnPT0=/900-vivriti-capital-limited-2026?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
  
  Repost Cancel
You will now receive notification when someone reply to this message.
sunny85deol
MF Investment Help
Follow

86 days ago

Hello sir, I have been invested in these funds since 2017. Last SIP was in 2021. As their NAV have grown so I was thinking of switching to other funds with lower NAV. View more

Posted by : sunny85deol
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Hello sir, I have been invested in these funds since 2017. Last SIP was in 2021. As their NAV have grown so I was thinking of switching to other funds with lower NAV.
  
  Repost Cancel
You will now receive notification when someone reply to this message.
Progrowth Finwealth
MF Investment Help
Follow

86 days ago

Hi Sunny, what is he period of holding and also any particular reson for withdrawl out of these two funds that have grown over a period of time View more | 1

Posted by : Progrowth Finwealth
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Hi Sunny, what is he period of holding and also any particular reson for withdrawl out of these two funds that have grown over a period of time
  
  Repost Cancel
You will now receive notification when someone reply to this message.
h_purandare
MF Investment Help
Follow

92 days ago

Why are the NAVs of Indian Debt Mutual Funds going down after the rate cut View more

Posted by : h_purandare
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Why are the NAVs of Indian Debt Mutual Funds going down after the rate cut
  
  Repost Cancel
You will now receive notification when someone reply to this message.

+ See More

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347